COVID Data = Money for Trump

Recently, the government changed the collection of data about Covid-19.  On March 29, VP Pence asked hospitals to report data through three different systems: the established network by the CDC, HHS Protect, and TeleTracking.

Then DHHS announced that hospitals must not report information about cases through the CDC system.  The CDC system has been in place for 15 years.  The other two have connections to Trump.  Previously, only the CDC collected this data. 

Very suspicious, right?

Palantir Technologies created HHS Protect. Palantir Technologies is a data-mining firm.  Trump Supporter Peter Thiel owns Palantir. Last month, he secretly filed paperwork to go public. An initial public offering (IPO) would profit from government contracts to collect Covid data.

The TeleTracking system also raises suspicions of a financial deal. Why did HHS award a $10 million no-bid contract to create this data system that duplicated the one the CDC already had. Remdesivir is a proven effective drug against Covid-19. Two weeks ago, the Trump administration bought up almost all of the world’s supply of the drug for the next three months.

The letter shifting data collection had the following addition.

“We will no longer be sending out requests for data to aid in the distribution of Remdesivir or any other treatments or supplies. This daily reporting is the only mechanism used for the distribution calculations. The daily is needed daily to ensure accurate calculations.”

“Now, it appears, in order to get access to it, hospitals will need to use the private data systems the administration supports.” 

So now whomever controls the data, controls where Remdesivir will go.